The ARHGAP32 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal cell population with targeted disruption of the ARHGAP32 gene in the HEK293T human embryonic kidney cell line. This knockout model enables loss-of-function studies of the encoded Rho GTPase-activating protein (RhoGAP) that negatively regulates Rho family GTPases, providing a versatile tool for investigating cytoskeletal dynamics, cell migration, and adhesion signaling.
HEK293T cells are an adherent epithelial cell line derived from human embryonic kidney, immortalized with adenovirus type 5 DNA, and characterized by high transfection efficiency and robust protein expression. Their well-established background in signaling research and recombinant protein production makes them an ideal host for genetic manipulation and pathway dissection, offering reproducible experimental conditions for studying GTPase regulatory networks.
ARHGAP32 encodes a GTPase-activating protein that accelerates GTP hydrolysis of Rho family GTPases, including RhoA, Rac1, and Cdc42, thereby terminating their active signaling states. This regulatory function is critical for actin cytoskeleton remodeling, as inactivation of these GTPases reduces actin stress fiber formation, lamellipodia dynamics, and filopodia extension. Upstream, ARHGAP32 activity is modulated by growth factor receptors, integrin adhesion receptors, and BDNF/TrkB signaling, linking extracellular cues to cytoskeletal reorganization. Downstream, it influences the actin cytoskeleton directly and modulates effectors such as ROCK, PAK, N-WASP, and the Arp2/3 complex, which drive various actin-based processes including cell migration, focal adhesion turnover, and axon guidance.
In HEK293T cells, disruption of ARHGAP32 provides a clean genetic background to dissect Rho GTPase signaling without the confounding influence of this GAP. This polyclonal knockout population is particularly suited for high-throughput screening efforts aimed at identifying Rho pathway modulators and for protein interaction studies using co-immunoprecipitation or pull-down assays. It also facilitates quantitative analysis of RhoA, Rac1, and Cdc42 activation levels via GTPase activation assays and Western blotting, enabling systematic interrogation of pathway kinetics in response to growth factor stimulation or pharmacological perturbation.
Typical research applications include functional analyses of cell migration, where the knockout cells can be subjected to scratch wound or transwell migration assays, and immunofluorescence microscopy to visualize changes in actin organization and focal adhesion morphology. This model is also relevant for neurodevelopmental disorder and cancer research, as aberrant ARHGAP32 function has been implicated in intellectual disability and tumor cell invasion. The ARHGAP32 knockout HEK293T polyclonal cells thus serve as a flexible platform for both mechanistic studies and drug discovery campaigns targeting Rho-dependent pathologies. For further technical specifications or custom formulations, please contact Ascent Research.
